Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2024-04-23 2026-03-02 225976
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-04-24 2026-03-02 255536
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-06-12 2025-04-24 230196
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-20 2023-10-03 187457
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-10-26 2022-11-29 172695
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-11-03 2021-11-09 148770
SANDOZ ZOPICLONE 5MG TABLET Resolved 2018-10-16 2023-11-17 64440
SANDOZ ZOPICLONE 5MG TABLET Resolved 2017-05-08 2017-05-15 9497
SANDOZ-CARBAMAZEPINE CR 200MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-02 2024-12-03 239131
SANDOZ-CARBAMAZEPINE CR 200MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-07 2019-05-09 83221
SANDOZ-CARBAMAZEPINE CR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-08-27 2024-10-29 236035
SANDOZ-CARBAMAZEPINE CR 400MG TABLET (EXTENDED-RELEASE) Resolved 2017-04-04 2017-06-06 5569
SANDOZ-CARBAMAZEPINE CR 200MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-11 2025-03-12 221829
SANDOZ-CARBAMAZEPINE CR 400MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-16 2023-11-28 207076
SANDOZ-CARBAMAZEPINE CR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-16 2025-03-12 225212
SANDOZ-CARBAMAZEPINE CR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-11-18 2020-01-22 99058
SANDOZ-DICLOFENAC 50MG TABLET (DELAYED-RELEASE) Resolved 2020-06-08 2023-11-17 116935
SANDOZ-DICLOFENAC 50MG TABLET (DELAYED-RELEASE) Resolved 2018-08-23 2019-05-07 58856
SANDOZ-DICLOFENAC 50MG SUPPOSITORY Resolved 2025-12-15 2025-12-15 274361
SANDOZ-DICLOFENAC 50MG TABLET (DELAYED-RELEASE) Resolved 2019-10-29 2020-01-22 97389
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136